These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11413003)

  • 21. The prion paradox: infection or polymerisation?
    Biro JC
    Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.
    Brim S; Groschup MH; Kuczius T
    PLoS One; 2016; 11(4):e0153931. PubMed ID: 27093554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper and the structural biology of the prion protein.
    Viles JH; Klewpatinond M; Nadal RC
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1288-92. PubMed ID: 19021542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein: orchestrating neurotrophic activities.
    Martins VR; Beraldo FH; Hajj GN; Lopes MH; Lee KS; Prado MA; Linden R
    Curr Issues Mol Biol; 2010; 12(2):63-86. PubMed ID: 19767651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion protein self-peptides modulate prion interactions and conversion.
    Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
    BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expanded octarepeat domain selectively binds prions and disrupts homomeric prion protein interactions.
    Leliveld SR; Dame RT; Wuite GJ; Stitz L; Korth C
    J Biol Chem; 2006 Feb; 281(6):3268-75. PubMed ID: 16352600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
    Redecke L; Meyer-Klaucke W; Koker M; Clos J; Georgieva D; Genov N; Echner H; Kalbacher H; Perbandt M; Bredehorst R; Voelter W; Betzel C
    J Biol Chem; 2005 Apr; 280(14):13987-92. PubMed ID: 15684434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
    Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion disease: A loss of antioxidant function?
    Wong BS; Pan T; Liu T; Li R; Petersen RB; Jones IM; Gambetti P; Brown DR; Sy MS
    Biochem Biophys Res Commun; 2000 Aug; 275(2):249-52. PubMed ID: 10964653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
    Leach SP; Salman MD; Hamar D
    Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prion protein and neuronal zinc homeostasis.
    Watt NT; Hooper NM
    Trends Biochem Sci; 2003 Aug; 28(8):406-10. PubMed ID: 12932728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.